Navigation Links
Brooks Kushman Stomps on Multiple Sclerosis: Local Law Firm Honored by Multiple Sclerosis Society for Fundraising Efforts
Date:11/24/2008

r their active participation and fundraising efforts," said John Halan, a shareholder involved in charity efforts for Brooks Kushman. "It's wonderful to see that even in tough economic times, individuals are willing to donate time and money to an organization that so heavily depends on such support and compassion."

Founded in 1983 by five intellectual property attorneys, Brooks Kushman has grown more than ten-fold to 70 professionals, gaining a reputation both nationally and internationally as a leader in providing cutting-edge, timely and cost-effective intellectual property counsel.

Brooks Kushman counts four U.S. Fortune 100 companies among its clients and is often recognized by peers and leading trade publications. Brooks Kushman is a Go-To Law Firm(R) selected by the top 500 companies, according to Corporate Counsel magazine; a "Best at Client Focus" firm, according to large and Fortune 1000 companies surveyed by The BTI Consulting Group; and one of the top IP firms selected by the Fortune 250, according to IP Law & Business. For more information, visit www.brookskushman.com .


'/>"/>
SOURCE Brooks Kushman P.C.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. More Efficient, Effective and Personal Patient Care at New McCune-Brooks Hospital Made Possible by Siemens HiPath(R) Wireless
2. Brooks and the University of Florida Reach Research Agreement
3. Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
4. Brooks Brothers CEO at St. Jude Childrens Research Hospital(R) To Announce Partnership With Stanford St. Jude Championship
5. Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs
6. Garth Brooks, Jon McLaughlin, and Pat Benatar and Neil Giraldo Raise Their Voices to Help Starkey Hearing Foundation Raise More Than $5 Million at Annual Fundraiser
7. Brooks(R) Sports Launches BioMoGo Biodegradable Shoe
8. Nonprofit Charity for Women and Brookstone Dash to Fund Breast Cancer Support
9. Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida
10. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
11. New MRI finding sheds light on multiple sclerosis disease progressio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...Working Families vs. Insurance Companies ,, HA...n the heels of an historic late night vote in the ...th care reform bill, the Pennsylvania AFL-CIO rele...atives voted on HR 3962, the Affordable Health Car...assed Saturday evening by a vote of 220 to 215, ta...
(Date:11/7/2009)...re/ -- Karen Ignagni, President and CEO of America...lowing statement today on House passage of H.R. 39...sive health care reform, and we have contributed t... of how health insurance is provided. Earlier this...n of pre-existing condition exclusions, no longer ...
(Date:11/7/2009)... -- The American Medical Association (AMA) proudly...amily Violence Prevention Fund, with the Citation ... policy-making meeting. The Citation for Distingu...f Delegates bestows on a non-physician. ,, (L...09/AMALOGO ) ,, "Ms. James has worked selfles...
(Date:11/7/2009)... -- Members of the AMA are trying a last-minute ta...ng the AMA,s support of HR 3962. ,, "We want t...heir PATIENTS, not the leadership of the AMA," sai...iation of American Physicians and Surgeons, and Ta...ups. ,, "If the AMA leadership ignores the pub...
(Date:11/7/2009)...re/ -- The U.S. bishops November 7 urged members o...pak-Ellsworth Amendment to the health care reform....er-Lipinski-Smith Amendment will keep in place cur...e protections in the Affordable Health Care for Am...r was signed by Cardinal Justin Rigali, chair of t...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...in Mental Illness Coverage commends the United Sta...arity Act of 2007, setting the stage for,enactment...use of the,leadership of Senators Pete V. Domenici...ical health care coverage for,American workers and...
...n the U.S. millions of blood donors see a critical...n. Of the 14.4 million units of whole blood collec... four million whole blood-derived platelet concent...o medical requirement or clear need to do so. Toda...
... and founder of the Center for Health Transformati...e Republican lawmakers on Capitol Hill,today that ...te in the,Congress over the State Children,s Healt...nds of poor children currently,enrolled in SCHIP a...
...TC: ABOS) today announced Walter C. Ogier has resi...ompany,s Board of Directors. The Arbios Board,of D...ice President of,Operations, to serve as interim P...my,Factor as Vice Chairman. Ms. Factor is a former...
... they play a significant role in making medical de...at the University of Michigan C.S. Mott Childrens ...er issue of the Journal of Pediatrics, 86 percent ...onfident communicating with physicians as well as...
...th cancer or have survived it, one factor may be m...: communication. In recognition of this, the Natio...rt by November 1, co-authored by a University of R...understand what is happening, how can patients mak...
Other Medicine News:Health News:Critical blood shortages eased by new technology 2Health News:Critical blood shortages eased by new technology 3Health News:Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a 'Clean' SCHIP Six-Month Extension 2Health News:Arbios Announces Management Changes 2Health News:Parents' participation in medical decisions linked to self-efficacy 2Health News:Communication in cancer world is key to survival 2
(Date:11/6/2009)...swire/ -- Facet Solutions, Inc. announced today th...hopedics. The acquisition creates an undisputed le...al property and clinical experience in posterior m...ffering from lumbar spinal stenosis," stated Facet...is consolidation further strengthens Facet Solutio...
(Date:11/6/2009)...ire-FirstCall/ -- Virtual Health Technologies, Inc...the previously confirmed Letter of Intent to sell ... Technologies, Inc (WNDM) is subject to final appr...f VHGI. ,, Shareholder Assurances ,, "We...y stream and cash realized from the transaction wo...
(Date:11/6/2009)...irstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDE...pment of small-molecule therapeutics for the treat...rus (HIV), today reported recent accomplishments a...e months ended September 30, 2009. ,, (Logo: ...ALOGO ) ,, "Since our last quarterly update, we...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer 13940 1EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer 13940 2Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid Market Life Sciences Companies 56552 1Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid Market Life Sciences Companies 56552 2Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid Market Life Sciences Companies 56552 3Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid Market Life Sciences Companies 56552 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 1KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 56547 6
...irect Investment in CEL-SCI, VIENNA, Va., Nov. 3 ... that it has expanded its exclusive licensing,agre... Ltd. ("Orient,Europharma"), a leading pharmaceuti... the Multikine collaboration to also cover South K...he licensing agreement,initially focuses on the ar...
... of data set closing, Top-line results expected in..., Nov. 3 Cell Therapeutics, Inc. (CTI),(Nasdaq an...e data set for,preliminary analysis of the primary...f pixantrone (BBR2278) for patients with relapsed ...and it has provided Novartis,notice that the data ...
Other Medicine Technology:CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine 2CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine 3Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial 2Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial 3Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial 4
... test kit is an immunochromatographic in vitro ass...lin E in human serum or plasma. Elevated concentra...athologies. It may also be caused by autoimmune di... using InstaTest IgE test kit will help in diagnos...
...e and patented design, the LifeSync(R) System elim...s and bedside, 12-lead or transport ECG monitors, ...al. Using highly-sophisticated Bluetooth(R) wirele...way radios to collect and transmit patient ECG and...
25-Hydroxy Vitamin D RIA
CoaguChek® Pro/DM
Medicine Products: